CA2300154C — Sterile bioerodible implant device with improved biocompatability and method
Assigned to Allergan Inc · Expires 2008-07-08 · 18y expired
What this patent protects
A plantable device is provided which incorpo-rates a retinoid for improving the biocompatibility of the device in tissue. The device may be bioerodible for the purpose of systemically or locally releasing a therapeutic agent in tissue or it may be a perma-nent implant which inclu…
USPTO Abstract
A plantable device is provided which incorpo-rates a retinoid for improving the biocompatibility of the device in tissue. The device may be bioerodible for the purpose of systemically or locally releasing a therapeutic agent in tissue or it may be a perma-nent implant which includes a surface treated with a retinoid for increasing the biocompatibility thereof.
Drugs covered by this patent
Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.
Track this patent
Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.